Digital pathology software firm PictorLabs announced that it has successfully completed its $30 million series B funding round.
The funding round was led by software investor Insight Partners with participation from M Ventures, the venture capital arm of Merck KGaA, which led PictorLabs' series A round.
The Los Angeles-based company, a spinoff from the University of California, Los Angeles colleges of engineering and medicine, specializes in artificial intelligence (AI)-powered virtual staining technology aimed at eliminating the need for reagents and producing digitally stained slides in minutes.
In a statement, PictorLab said it will use the funding to advance its technology further, expand its market reach, and accelerate the adoption of its AI-driven virtual staining in research and clinical settings.
